ASF1B and hepatocellular carcinoma: In Hep3B, the proportion of S stage in knockout ASF1B group was 37.8%, while that in control group was 35.6%.Combining the two results, it is suggested that ASF1B knockdown can lead to cell cycle S and G2 phase arrest of HCC cells (Figure 7B).